doi: 10.1056/NEJMp078032.
The FDA and the case of Ketek
Affiliations
- PMID: 17442902
- DOI: 10.1056/NEJMp078032
Item in Clipboard
The FDA and the case of Ketek
N Engl J Med.
.
Free article
No abstract available
Comment in
-
Ketek--the FDA perspective.N Engl J Med. 2007 Apr 19;356(16):1675-6. doi: 10.1056/NEJMc076135. N Engl J Med. 2007. PMID: 17442912 No abstract available.
Similar articles
-
Ketek--the FDA perspective.N Engl J Med. 2007 Apr 19;356(16):1675-6. doi: 10.1056/NEJMc076135. N Engl J Med. 2007. PMID: 17442912 No abstract available.
-
Fraud, errors taint a key study of widely used Sanofi drug; despite some faked results, FDA approves antibiotic; one doctor's cocaine use; company defends safety.Wall St J (East Ed). 2006 May 1:A1, A12. Wall St J (East Ed). 2006. PMID: 16838449 No abstract available.
-
Telithromycin and acute liver failure.N Engl J Med. 2006 Nov 23;355(21):2260-1. doi: 10.1056/NEJMc066372. N Engl J Med. 2006. PMID: 17124030 No abstract available.
-
Understanding the regulatory hurdles for antibacterial drug development in the post-Ketek world.Ann N Y Acad Sci. 2011 Dec;1241:153-61. doi: 10.1111/j.1749-6632.2011.06300.x. Ann N Y Acad Sci. 2011. PMID: 22191531 Review.
-
The FDA's new oncology office.Clin Adv Hematol Oncol. 2005 Aug;3(8):612-3. Clin Adv Hematol Oncol. 2005. PMID: 16167044 Review. No abstract available.
Cited by
-
Applications for oncologic drugs: a descriptive analysis of the oncologic drugs advisory committee reviews.Oncologist. 2014 Mar;19(3):299-304. doi: 10.1634/theoncologist.2013-0276. Epub 2014 Mar 5. Oncologist. 2014. PMID: 24599479 Free PMC article.
-
Investigator Responsibilities in Clinical Research.Ochsner J. 2020 Spring;20(1):44-49. doi: 10.31486/toj.19.0085. Ochsner J. 2020. PMID: 32284682 Free PMC article. Review.
-
Medicine. Moving toward transparency of clinical trials.Science. 2008 Mar 7;319(5868):1340-2. doi: 10.1126/science.1153632. Science. 2008. PMID: 18323436 Free PMC article. No abstract available.
-
The Role of Five-Membered Heterocycles in the Molecular Structure of Antibacterial Drugs Used in Therapy.Pharmaceutics. 2023 Oct 29;15(11):2554. doi: 10.3390/pharmaceutics15112554. Pharmaceutics. 2023. PMID: 38004534 Free PMC article. Review.
-
Preemption, tort reform, and pharmaceutical claims: Part one: Who will become the pharmaceutical industry's insurers (or is it prescribing physicians and we do not know it?).Proc (Bayl Univ Med Cent). 2007 Oct;20(4):418-22. doi: 10.1080/08998280.2007.11928337. Proc (Bayl Univ Med Cent). 2007. PMID: 17948120 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
